mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.2 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.2 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.2 |
mRNA |
PHA-793887 |
GDSC1000 |
pan-cancer |
AAC |
0.041 |
0.2 |
mRNA |
necrostatin-7 |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.2 |
mRNA |
OSI-930 |
GDSC1000 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
R428 |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.2 |
mRNA |
BI-2536 |
FIMM |
pan-cancer |
AAC |
0.18 |
0.2 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.2 |